These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 35899316)

  • 1. Gastrointestinal dysbiosis and Escherichia coli pathobionts in inflammatory bowel diseases.
    Petersen AM
    APMIS; 2022 Aug; 130 Suppl 144(Suppl 144):1-38. PubMed ID: 35899316
    [No Abstract]   [Full Text] [Related]  

  • 2.
    Mirsepasi-Lauridsen HC; Vallance BA; Krogfelt KA; Petersen AM
    Clin Microbiol Rev; 2019 Mar; 32(2):. PubMed ID: 30700431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A potential role of Escherichia coli pathobionts in the pathogenesis of pediatric inflammatory bowel disease.
    Schippa S; Iebba V; Totino V; Santangelo F; Lepanto M; Alessandri C; Nuti F; Viola F; Di Nardo G; Cucchiara S; Longhi C; Conte MP
    Can J Microbiol; 2012 Apr; 58(4):426-32. PubMed ID: 22439600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adherent-invasive
    Palmela C; Chevarin C; Xu Z; Torres J; Sevrin G; Hirten R; Barnich N; Ng SC; Colombel JF
    Gut; 2018 Mar; 67(3):574-587. PubMed ID: 29141957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbiota dysbiosis in inflammatory bowel diseases: in silico investigation of the oxygen hypothesis.
    Henson MA; Phalak P
    BMC Syst Biol; 2017 Dec; 11(1):145. PubMed ID: 29282051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherent-invasive Escherichia coli Exacerbates Antibiotic-associated Intestinal Dysbiosis and Neutrophil Extracellular Trap Activation.
    Vong L; Yeung CW; Pinnell LJ; Sherman PM
    Inflamm Bowel Dis; 2016 Jan; 22(1):42-54. PubMed ID: 26398709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Propionate catabolism by CD-associated adherent-invasive
    Agus A; Richard D; Faïs T; Vazeille E; Chervy M; Bonnin V; Dalmasso G; Denizot J; Billard E; Bonnet R; Buisson A; Barnich N; Delmas J
    Gut Microbes; 2021; 13(1):1-18. PubMed ID: 33769191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of Escherichia coli in inflammatory bowel disease.
    Rhodes JM
    Gut; 2007 May; 56(5):610-2. PubMed ID: 17440180
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enterovirulent E. coli in inflammatory and noninflammatory bowel diseases.
    Curová K; Kmetová M; Sabol M; Gombosová L; Lazúrová I; Siegfried L
    Folia Microbiol (Praha); 2009; 54(1):81-6. PubMed ID: 19330549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherent-invasive Escherichia coli (AIEC): Cause or consequence of inflammation, dysbiosis, and rupture of cellular joints in patients with IBD?
    Perna A; Hay E; Contieri M; De Luca A; Guerra G; Lucariello A
    J Cell Physiol; 2020 Jun; 235(6):5041-5049. PubMed ID: 31898324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota changes in inflammatory bowel diseases and ankylosing spondilytis.
    Cardoneanu A; Mihai C; Rezus E; Burlui A; Popa I; Cijevschi Prelipcean C
    J Gastrointestin Liver Dis; 2021 Mar; 30(1):46-54. PubMed ID: 33548121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiota dysbiosis and barrier dysfunction in inflammatory bowel disease and colorectal cancers: exploring a common ground hypothesis.
    Yu LC
    J Biomed Sci; 2018 Nov; 25(1):79. PubMed ID: 30413188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota, inflammatory bowel disease and colorectal cancer.
    Quaglio AEV; Grillo TG; De Oliveira ECS; Di Stasi LC; Sassaki LY
    World J Gastroenterol; 2022 Aug; 28(30):4053-4060. PubMed ID: 36157114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune susceptibility gene
    Spalinger MR; Shawki A; Chatterjee P; Canale V; Santos A; Sayoc-Becerra A; Scharl M; Tremblay ML; Borneman J; McCole DF
    Gut; 2022 Jan; 71(1):89-99. PubMed ID: 33563644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Professor Arlette Darfeuille-Michaud: the discovery of adherent-invasive Escherichia coli.
    Yang Y; Jobin C
    J Crohns Colitis; 2015 May; 9(5):373-5. PubMed ID: 25759068
    [No Abstract]   [Full Text] [Related]  

  • 16. The Role of Enterobacteriaceae in Gut Microbiota Dysbiosis in Inflammatory Bowel Diseases.
    Baldelli V; Scaldaferri F; Putignani L; Del Chierico F
    Microorganisms; 2021 Mar; 9(4):. PubMed ID: 33801755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escherichia coli dysbiosis correlates with gastrointestinal dysfunction in children with cystic fibrosis.
    Hoffman LR; Pope CE; Hayden HS; Heltshe S; Levy R; McNamara S; Jacobs MA; Rohmer L; Radey M; Ramsey BW; Brittnacher MJ; Borenstein E; Miller SI
    Clin Infect Dis; 2014 Feb; 58(3):396-9. PubMed ID: 24178246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutrition, oxidative stress and intestinal dysbiosis: Influence of diet on gut microbiota in inflammatory bowel diseases.
    Tomasello G; Mazzola M; Leone A; Sinagra E; Zummo G; Farina F; Damiani P; Cappello F; Gerges Geagea A; Jurjus A; Bou Assi T; Messina M; Carini F
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Dec; 160(4):461-466. PubMed ID: 27812084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Enteric microflora in inflammatory bowel disease patients].
    Rahmouni O; Dubuquoy L; Desreumaux P; Neut C
    Med Sci (Paris); 2016 Nov; 32(11):968-973. PubMed ID: 28008837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes.
    Lopez-Siles M; Martinez-Medina M; Busquets D; Sabat-Mir M; Duncan SH; Flint HJ; Aldeguer X; Garcia-Gil LJ
    Int J Med Microbiol; 2014 May; 304(3-4):464-75. PubMed ID: 24713205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.